Search

Your search keyword '"Date A"' showing total 33,935 results

Search Constraints

Start Over You searched for: Author "Date A" Remove constraint Author: "Date A"
33,935 results on '"Date A"'

Search Results

251. RIFM fragrance ingredient safety assessment, geranyl isovalerate, CAS Registry Number 109-20-6

252. Update to RIFM fragrance ingredient safety assessment, 2-methylbutanol, CAS Registry Number 137-32-6

253. RIFM fragrance ingredient safety assessment, geranyl formate, CAS Registry Number 105-86-2

254. RIFM fragrance ingredient safety assessment, phenylacetaldehyde 2,4-dihydroxy-2-methylpentane acetal, CAS Registry Number 67633-94-7

255. RIFM fragrance ingredient safety assessment, patchouli alcohol, CAS Registry Number 5986-55-0

256. RIFM fragrance ingredient safety assessment, 5,6,7-trimethylocta-2,5-dien-4-one, CAS Registry Number 358331-95-0

257. RIFM fragrance ingredient safety assessment, 2-methylpropyl 3-methylbutyrate, CAS Registry Number 589-59-3

258. RIFM fragrance ingredient safety assessment, propyl butyrate, CAS Registry Number 105-66-8

259. RIFM fragrance ingredient safety assessment, geranyl isobutyrate, CAS Registry Number 2345-26-8

260. RIFM fragrance ingredient safety assessment, cyclohexanone,5-methyl-2-(1-methylethyl)-,oxime, CAS registry number 19096-86-7

261. RIFM fragrance ingredient safety assessment, phytol, CAS Registry Number 150-86-7

262. RIFM fragrance ingredient safety assessment, geranyl butyrate, CAS Registry Number 106-29-6

263. RIFM fragrance ingredient safety assessment, ω-6-hexadecenlactone, CAS Registry Number 7779-50-2

264. RIFM fragrance ingredient safety assessment, α-methylbenzyl isobutyrate, CAS Registry Number 7775-39-5

265. RIFM fragrance ingredient safety assessment, 4-hydroxy-3-pentenoic acid lactone, CAS Registry number 591-12-8

272. Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely Resected p-Stage II-IIIA Non–Small-Cell Lung Cancer: A Retrospective Cohort Study Using Japanese Nationwide Real-World Data

276. The Deep Space Radiation Probe: Development of a first lunar science payload for space environment studies and capacity building

278. Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy

288. Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study

289. Encoding integers and rationals on neuromorphic computers using virtual neuron

290. Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%

292. The Effect of a Loading Dose Regimen in the Switch to Brolucizumab for Patients with Aflibercept-Resistant nAMD

293. Statistical modeling of pneumothorax deformation by mapping CT and cone-beam CT images

294. On viscid-inviscid interactions of a pair of bubbles rising near the wall

295. Analysis of Heterogeneity of Pneumothorax-associated Deformation using Model-based Registration

296. Quantum Discriminator for Binary Classification

297. Training Deep Neural Networks with Constrained Learning Parameters

298. Adiabatic Quantum Optimization Fails to Solve the Knapsack Problem

299. Balanced k-Means Clustering on an Adiabatic Quantum Computer

300. QUBO Formulations for Training Machine Learning Models

Catalog

Books, media, physical & digital resources